Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Theodoros P. Vassilakopoulos, Georgia Levidou, Vassilis Milionis, Sylvia Hartmann, Eleftheria Lakiotaki, Athanasia Sepsa, Irene Thymara, Panagiota Ntailiani, Kallirroi Spanou, Maria K. Angelopoulou, Marina P. Siakantaris, Maria Moschogiannis, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Kostas Konstantopoulos, Efstratios Patsouris, Martin-Leo Hansmann & Penelope Korkolopoulou. (2017) Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications. Leukemia & Lymphoma 58:9, pages 2227-2239.
Read now
Read now
Benjamin Rengstl, Frederike Schmid, Christian Weiser, Claudia Döring, Tim Heinrich, Kathrin Warner, Petra S. A. Becker, Robin Wistinghausen, Sima Kameh-Var, Eva Werling, Arne Billmeier, Christian Seidl, Sylvia Hartmann, Hinrich Abken, Ralf Küppers, Martin-Leo Hansmann & Sebastian Newrzela. (2016) Tumor-infiltrating HLA-matched CD4+ T cells retargeted against Hodgkin and Reed–Sternberg cells. OncoImmunology 5:6.
Read now
Read now
Francesco Gaudio, Tommasina Perrone, Anna Mestice, Paola Curci, Annamaria Giordano, Mario Delia, Domenico Pastore & Giorgina Specchia. (2014) Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma. Leukemia & Lymphoma 55:7, pages 1596-1601.
Read now
Read now
Simon J. Harrison, Andy K. Hsu, Paul Neeson, Anas Younes, Anna Sureda, Andreas Engert, H. Miles Prince, Martha Li, Paula Savage, Roberto Bugarini, Denise Williams, Margaret Squier & David S. Ritchie. (2014) Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. Leukemia & Lymphoma 55:5, pages 1053-1060.
Read now
Read now
Udai P. Singh, Narendra P. Singh, Brandon Busbee, H. Guan, Balwan Singh, Robert L. Price, Dennis D. Taub, Manoj K. Mishra, Mitzi Nagarkatti & Prakash S. Nagarkatti. (2012) Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases. International Reviews of Immunology 31:1, pages 66-84.
Read now
Read now
Alana A. Kennedy-Nasser, Patrick Hanley & Catherine M. Bollard. (2011) Hodgkin Disease and the Role of the Immune System. Pediatric Hematology and Oncology 28:3, pages 176-186.
Read now
Read now
Brian M Nolen & Anna E Lokshin. (2010) Targeting CCL11 in the treatment of ovarian cancer. Expert Opinion on Therapeutic Targets 14:2, pages 157-167.
Read now
Read now
Roger Rautert, Timo Schinköthe, Jeremy Franklin, Martin Weihrauch, Boris Böll, Elke Pogge, Henning Bredenfeld, Andreas Engert, Volker Diehl & Daniel Re. (2008) Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leukemia & Lymphoma 49:11, pages 2091-2098.
Read now
Read now
Donatella Aldinucci, Karin Olivo, Debora Lorenzon, Dalisa Poletto, Annunziata Gloghini, Antonino Carbone & Antonio Pinto. (2005) The role of interleukin-3 in classical Hodgkin's disease. Leukemia & Lymphoma 46:3, pages 303-311.
Read now
Read now
Donatella Aldinucci, Debora Lorenzon, Karin Olivo, Barbara Rapanà & Valter Gattei. (2004) Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells. Leukemia & Lymphoma 45:9, pages 1731-1739.
Read now
Read now
Ulla Axdorph, Anna Porwit-MacDonald, Gunnar Grimfors & Magnus Björkholm. (2001) Tissue Eosinophilia in Relation to Immunopathological and Clinical Characteristics in Hodgkin's Disease. Leukemia & Lymphoma 42:5, pages 1055-1065.
Read now
Read now
Articles from other publishers (57)
Audi Setiadi, Adi Zoref-Lorenz, Christina Y Lee, Michael B Jordan & Luke Y C Chen. (2022) Malignancy-associated haemophagocytic lymphohistiocytosis. The Lancet Haematology 9:3, pages e217-e227.
Crossref
Crossref
Anja Mottok. (2021) Tumormikromilieu im klassischen Hodgkin-LymphomMicroenvironment in classical Hodgkin lymphoma. Wiener klinisches Magazin 24:3, pages 122-128.
Crossref
Crossref
Eline A. M. Zijtregtop, Iris van der Strate, Auke Beishuizen, Christian M. Zwaan, Marijn A. Scheijde-Vermeulen, Arianne M. Brandsma & Friederike Meyer-Wentrup. (2021) Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma. Cancers 13:4, pages 884.
Crossref
Crossref
Mark Jaradeh, Nausheen Baig, Emily Bontekoe, Mirjana Mitrovic, Darko Antic, Debra Hoppensteadt, Bulent Kantarcioglu & Jawed Fareed. (2021) The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962110503.
Crossref
Crossref
Eline A. M. Zijtregtop, Friederike Meyer‐Wentrup, Wai‐Chu Wong, Raoull Hoogendijk, Marta Lopez‐Yurda, Christian M. Zwaan & Auke Beishuizen. (2020) Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma. eJHaem 1:1, pages 152-160.
Crossref
Crossref
Anja Mottok. (2020) Tumormikromilieu im klassischen Hodgkin-LymphomMicroenvironment in classical Hodgkin lymphoma. Der Pathologe 41:3, pages 254-260.
Crossref
Crossref
Ryan Incrocci, Jason McAloon, Michael Montesano, Jonathan Bardahl, Saivenkat Vagvala, Amanda Stone & Michelle Swanson-Mungerson. (2019) Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production. Journal of Medical Virology 91:5, pages 845-855.
Crossref
Crossref
Geok Tan, Lydia Visser, Lu Tan, Anke Berg & Arjan Diepstra. (2018) The Microenvironment in Epstein–Barr Virus-Associated Malignancies. Pathogens 7:2, pages 40.
Crossref
Crossref
Jessicca D. Abron, Narendra P. Singh, Angela E. Murphy, Manoj K. Mishra, Robert L. Price, Mitzi Nagarkatti, Prakash S. Nagarkatti & Udai P. Singh. (2018) Differential role of CXCR3 in inflammation and colorectal cancer. Oncotarget 9:25, pages 17928-17936.
Crossref
Crossref
Jodi Chiu, Daniel M. Ernst & Armand Keating. (2018) Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma. Frontiers in Immunology 9.
Crossref
Crossref
Benjamin Rengstl, Sooji Kim, Claudia Döring, Christian Weiser, Julia Bein, Katrin Bankov, Marco Herling, Sebastian Newrzela, Martin-Leo Hansmann & Sylvia Hartmann. (2017) Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other. PLOS ONE 12:5, pages e0177378.
Crossref
Crossref
Kung-Chao Chang, Paul C-H Chen, Yao Chang, Yu-Hsuan Wu, Ya-Ping Chen, Chien-Hsien Lai, L Jeffrey Medeiros, Ih-Jen Su & Hsei-Wei Wang. (2017) Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma. Histopathology 70:3, pages 442-455.
Crossref
Crossref
José Luis Piñana, Jaime Sanz, Albert Esquirol, Rodrigo Martino, Alessandra Picardi, Pere Barba, Rocio Parody, Jorge Gayoso, Pau Montesinos, Stefano Guidi, Maria José Terol, Federico Moscardó, Carlos Solano, William Arcese, Miguel A. Sanz, Jorge Sierra & Guillermo Sanz. (2016) Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease. European Journal of Haematology 96:2, pages 128-135.
Crossref
Crossref
Antonino Carbone & Anas YounesMaria Costanza Aquilano & Antonino Carbone. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2)
2
19
.
Antonino Carbone & Anas Younes. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2).
Katrien Van Raemdonck, Philippe E. Van den Steen, Sandra Liekens, Jo Van Damme & Sofie Struyf. (2015) CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 26:3, pages 311-327.
Crossref
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology
91
116
.
Martina Vockerodt, Lee-Fah Yap, Claire Shannon-Lowe, Helen Curley, Wenbin Wei, Katerina Vrzalikova & Paul G Murray. (2015) The Epstein-Barr virus and the pathogenesis of lymphoma. The Journal of Pathology 235:2, pages 312-322.
Crossref
Crossref
Olga Bohn, Takahiro Maeda, Alexander Filatov, Andrea Lunardi, Pier Paolo Pandolfi & Julie Teruya-Feldstein. (2013) Utility of LRF/Pokemon and NOTCH1 Protein Expression in the Distinction Between Nodular Lymphocyte-Predominant Hodgkin Lymphoma and Classical Hodgkin Lymphoma. International Journal of Surgical Pathology 22:1, pages 6-11.
Crossref
Crossref
Yuxuan Liu, Ahmad Sattarzadeh, Arjan Diepstra, Lydia Visser & Anke van den Berg. (2014) The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component. Seminars in Cancer Biology 24, pages 15-22.
Crossref
Crossref
Alberto Mantovani, Maria Rosaria Galdiero, Paola Allavena & Antonio Sica. 2013. Cancer Immunotherapy. Cancer Immunotherapy
451
471
.
Kara M. Kelly. (2011) Management of children with high‐risk Hodgkin lymphoma. British Journal of Haematology 157:1, pages 3-13.
Crossref
Crossref
Christian SteidlJoseph M. ConnorsRandy D. Gascoyne. (2011) Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment. Journal of Clinical Oncology 29:14, pages 1812-1826.
Crossref
Crossref
Rafael D Gaiolla, Maria A. C Domingues, Lígia Niéro-Melo & Deilson Elgui de Oliveira. (2011) Serum Levels of Interleukins 6, 10, and 13 Before and After Treatment of Classic Hodgkin Lymphoma. Archives of Pathology & Laboratory Medicine 135:4, pages 483-489.
Crossref
Crossref
Katrina Farrell & Ruth F Jarrett. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology 58:1, pages 15-25.
Crossref
Crossref
Shoko Nakayama-Ichiyama, Taiji Yokote, Kichinosuke Kobayashi, Yuji Hirata, Toshikazu Akioka, Nobuya Hiraoka, Ayami Takayama, Kazuki Iwaki, Satoko Oka, Takayuki Takubo, Motomu Tsuji & Toshiaki Hanafusa. (2010) Multiple cytokine-producing mixed cellularity classical Hodgkin lymphoma with B symptoms and minimal change nephrotic syndrome. Leukemia Research 34:7, pages e157-e159.
Crossref
Crossref
Erik Andersson, Frida Schain, Jan Sjöberg, Magnus Björkholm & Hans-Erik Claesson. (2010) Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236. Experimental Hematology 38:2, pages 116-123.
Crossref
Crossref
Junichi Shiraishi, Yasunori Nakagawa, Morito Kurata, Kohei Yamamoto, Yu Abe, Yukitoshi Toyoda, Kenshi Suzuki, Masanobu Kitagawa & Tamiko Takemura. (2008) Follicular lymphoma with marked infiltration of eosinophils. Pathology International 58:11, pages 701-705.
Crossref
Crossref
Karl R.N. Baumforth, Anna Birgersdotter, Gary M. Reynolds, Wenbin Wei, Georgia Kapatai, Joanne R. Flavell, Emma Kalk, Karen Piper, Steve Lee, Lee Machado, Kerry Hadley, Anne Sundblad, Jan Sjoberg, Magnus Bjorkholm, Anna A. Porwit, Lee-Fah Yap, Soohwang Teo, Richard G. Grundy, Lawrence S. Young, Ingemar Ernberg, Ciaran B.J. Woodman & Paul G. Murray. (2008) Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells. The American Journal of Pathology 173:1, pages 195-204.
Crossref
Crossref
John West & Blossom Damania. (2008) Upregulation of the TLR3 Pathway by Kaposi's Sarcoma-Associated Herpesvirus during Primary Infection. Journal of Virology 82:11, pages 5440-5449.
Crossref
Crossref
Yue Ma, Lydia Visser, Tjasso Blokzijl, Geert Harms, Çiǧdem Atayar, Sibrand Poppema & Anke van den Berg. (2008) The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile. Laboratory Investigation 88:5, pages 482-490.
Crossref
Crossref
Marijke Niens, Lydia Visser, Ilja M. Nolte, Gerrit van der Steege, Arjan Diepstra, Pablo Cordano, Ruth F. Jarrett, Gerard J. te Meerman, Sibrand Poppema & Anke van den Berg. (2008) Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. British Journal of Haematology 140:5, pages 527-536.
Crossref
Crossref
Donatella Aldinucci, Debora Lorenzon, Lara Cattaruzza, Antonio Pinto, Annunziata Gloghini, Antonino Carbone & Alfonso Colombatti. (2008) Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer 122:4, pages 769-776.
Crossref
Crossref
Gunilla Enblad, Daniel Molin, Ingrid Glimelius, Marie Fischer & Gunnar Nilsson. (2007) The Potential Role of Innate Immunity in the Pathogenesis of Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America 21:5, pages 805-823.
Crossref
Crossref
Shosaku Nomura, Kazuyoshi Ishii, Yuka Kamitsuji, Nobuhiko Uoshima, Emiko Ishikawa, Hitoshi Kitayama & Kunio Hayashi. (2016) Elevation of Activated Platelet-Dependent Chemokines in Patients With Anti-CD20 Monoclonal Antibody (Rituximab)−Treated Non-Hodgkin's Lymphoma. Clinical and Applied Thrombosis/Hemostasis 13:2, pages 206-212.
Crossref
Crossref
S. Nomura, K. Iishii, N. Inami, E. Kimura & F. Urase. (2007) Elevation of Activated Platelet-Dependent Chemokines and Soluble Cell Adhesion Molecules in Patients with Hematologic Malignancies and High Levels of β-<i>D</i>-Glucan. Pathophysiology of Haemostasis and Thrombosis 36:1, pages 32-39.
Crossref
Crossref
Alberto Mantovani, Paola Allavena & Antonio Sica. 2007. Cancer Immunotherapy. Cancer Immunotherapy
289
307
.
Victor YazbeckGeorgios V GeorgakisAmanda WedgwoodAnas Younes. (2006) Hodgkin’s lymphoma: molecular targets and novel treatment strategies. Future Oncology 2:4, pages 533-551.
Crossref
Crossref
Marc Weniger, Thomas Barth & Peter Möller. (2006) Genomic Alterations in Hodgkin's Lymphoma. International Journal of Hematology 83:5, pages 379-384.
Crossref
Crossref
Antonio Sica, Tiziana Schioppa, Alberto Mantovani & Paola Allavena. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. European Journal of Cancer 42:6, pages 717-727.
Crossref
Crossref
Michael M Reily, Carlos Pantoja, Xiaoyu Hu, Yurii Chinenov & Inez Rogatsky. (2005) The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. The EMBO Journal 25:1, pages 108-117.
Crossref
Crossref
K. Karube, K. Ohshima, J. Suzumiya, R. Kawano, M. Kikuchi & M. Harada. (2006) Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed–Sternberg (HRS) cells: high expression of interleukin-11 receptor α. Annals of Oncology 17:1, pages 110-116.
Crossref
Crossref
. 2006. The Lymphomas. The Lymphomas
476
499
.
Lucy A. Truman, Carol Anne Ogden, Sarah E.M. Howie & Christopher D. Gregory. (2004) Macrophage chemotaxis to apoptotic Burkitt's lymphoma cells in vitro: role of CD14 and CD36. Immunobiology 209:1-2, pages 21-30.
Crossref
Crossref
Shuichi Fujita, Nathan Buziba, Atsushi Kumatori, Masachika Senba, Akira Yamaguchi & Kan Toriyama. (2004) Early Stage of Epstein-Barr Virus Lytic Infection Leading to the “Starry Sky” Pattern Formation in Endemic Burkitt Lymphoma. Archives of Pathology & Laboratory Medicine 128:5, pages 549-552.
Crossref
Crossref
Todd S. Barry, Elaine S. Jaffe, Lynn Sorbara, Mark Raffeld & Stefania Pittaluga. (2003) Peripheral T-Cell Lymphomas Expressing CD30 and CD15. The American Journal of Surgical Pathology 27:12, pages 1513-1522.
Crossref
Crossref
Cindy L. Schwartz. (2003) Prognostic factors in pediatric Hodgkin disease. Current Oncology Reports 5:6, pages 498-504.
Crossref
Crossref
Scott J. Rodig, Dan Jones, Aliakbar Shahsafaei & David M. Dorfman. (2002) CCR6 is a functional chemokine receptor that serves to identify select B-cell non-hodgkin's lymphomas. Human Pathology 33:12, pages 1227-1233.
Crossref
Crossref
Ewerton M. Maggio, Anke Van den Berg, Lydia Visser, Arjan Diepstra, Joust Kluiver, Roelke Emmens & Sibrand Poppema. (2002) Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas. International Journal of Cancer 99:5, pages 665-672.
Crossref
Crossref
Henry Pitot & Daniel Loeb. 2002. Fundamentals of Oncology, Revised and Expanded. Fundamentals of Oncology, Revised and Expanded
783
816
.
E. Maggio, A. van den Berg, A. Diepstra, J. Kluiver, L. Visser & S. Poppema. (2002) Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Annals of Oncology 13, pages 52-56.
Crossref
Crossref
Koichi Ohshima, Takeshi Tutiya, Takahiro Yamaguchi, Keiko Suzuki, Junji Suzumiya, Chika Kawasaki, Seiji Haraoka & Masahiro Kikuchi. (2002) Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. International Journal of Cancer 98:4, pages 567-572.
Crossref
Crossref
Wolfram J. JabsHans J. WagnerSusanne MaurmannHolger HennigBurkhard Kreft. (2002) Inhibition of macrophage inflammatory protein–1α production by Epstein-Barr virus. Blood 99:5, pages 1512-1516.
Crossref
Crossref
Uta E. HöpkenHans-Dieter FossDagmar MeyerMichael HinzKorinna LederHarald SteinMartin Lipp. (2002) Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99:4, pages 1109-1116.
Crossref
Crossref
Katharina Clodi, Zahra Asgari, Mamoun Younes, J. Lynn Palmer, Fernando Cabanillas, Antonino Carbone, Michael Andreeff & Anas Younes. (2002) Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease. Cancer 94:1, pages 1-5.
Crossref
Crossref
Cyrus V Hedvat, Elaine S Jaffe, Jing Qin, Daniel A Filippa, Carlos Cordon-Cardo, Giovanna Tosato, Stephen D Nimer & Julie Teruya-Feldstein. (2001) Macrophage-Derived Chemokine Expression in Classical Hodgkin's Lymphoma: Application of Tissue Microarrays. Modern Pathology 14:12, pages 1270-1276.
Crossref
Crossref
Paolo FiumaraFernando CabanillasAnas Younes. (2001) Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers. Blood 98:9, pages 2877-2878.
Crossref
Crossref